Bill Sibold

Bill Sibold

President and Chief Executive OfficeratMadrigal Pharmaceuticals· In proxies 2023–2025

Pay in FY2025+57% from the year before · Madrigal Pharmaceuticals stock +88.7% the same year

Bill Sibold was paid $19.2M in FY2025 (Dec), up 57%. Madrigal Pharmaceuticals stock rose 88.7% that year.

Pay$100 in the stock at the end of FY22 → $201
Pay is from the Summary Compensation Table of each Madrigal Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Madrigal PharmaceuticalsPublic company · 3 yr
    • President and Chief Executive Officer2023 – Present · 3 yrStock in role +65%

Roles come from the proxy statements of each company.

Boards1

  • Madrigal PharmaceuticalsDirector · 2 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?